Graham Capital Management, L.P. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,087,000
+24.8%
68,126
+7.5%
0.04%
+22.9%
Q2 2022$871,000
-5.0%
63,367
+9.5%
0.04%
+9.4%
Q1 2022$917,00057,8450.03%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders